跳至主要内容

Aim at chemical synthesis through Ibuprofen

 Recently, Pfizer's new crown-specific drug Paxlovid and the national miracle drug Ibuprofen are the most popular drugs in the medical circle. Today we will talk about the synthesis and mechanism of action of Ibuprofen, an evergreen drug! Recently, Ibuprofen has been hard to find, and it has become a well-known hard currency.

Ibuprofen

Ibuprofen, molecular formula C13H18O2, chemical name 2-(4-Isobutylphenyl) propanoic acid. Ibuprofen is a commonly used non-steroidal anti-inflammatory drug (NSAID). By inhibiting cyclooxygenase and reducing the synthesis of prostaglandins, it produces analgesic and anti-inflammatory effects; it acts as an antipyretic through the hypothalamic thermoregulatory center effect. Ibuprofen is generally well tolerated and does not cause clinically significant acute liver injury.

Chemical structure of ibuprofen.webp

 Ibuprofen chemical struture

 Indications for Ibuprofen

Oral administration: used to relieve mild to moderate pain, such as arthralgia, neuralgia, muscle pain, migraine, headache, dysmenorrhea, and toothache, and also reduces fever caused by the common cold or influenza.

Injection administration: for antipyretic and analgesic treatment: treatment of mild to moderate pain, adjunct to opioid analgesics for treating moderate to severe pain; antipyretic therapy of fever.

Mechanism of Action of Ibuprofen

Ibuprofen is a diastereoisomeric chiral drug, including R-ibuprofen and S-ibuprofen. Pharmacokinetic studies indicate that most of the pharmacologically active form of the drug is contributed by its S-enantiomer, which inhibits prostaglandin synthesis. A unidirectional enzymatic conversion of the inactive R-enantiomer to the active S-enantiomer was first reported in the early to mid-1970s. Approximately 40-60% of the R-enantiomer is metabolized in the liver to the S-ibuprofen form. Its anti-inflammatory effect is due to the inhibitory activity of S-ibuprofen on cyclooxygenase (COX), which is responsible for the synthesis of prostaglandins and plays an essential role in neuronal death mediated by exacerbated inflammatory responses. Ibuprofen inhibits COX, reduces nitric oxide (NO) production, and activates peroxisome proliferator-activated receptor-gamma (PPAR-gamma).

Mechanism of action of ibuprofen.webp

 Mechanism of action of Ibuprofen [1]

 Chemical Synthesis of Ibuprofen

Ibuprofen was first patented by Boots Pure Chemical Company in 1961 and approved as an over-the-counter drug in 1984. Since its inception, Ibuprofen has been sold under several brands, including Advil® and Motrin®. The synthesis of Ibuprofen starts from isobutyl benzene. The synthesis procedure includes Friedel-Crafts acylation, reduction, chloride substitution, and Grignard reaction. The products of each step were then analyzed by IR and 1 H NMR spectroscopy, and the final product was confirmed by analysis of melting points.

In 1992, BHC Corporation developed a new sustainable synthesis method that cut the synthesis steps in half. The first step uses anhydrous hydrogen fluoride as a catalyst and solvent, which is then recycled for reuse. Furthermore, the natural beauty behind the BHC method is the reduction of unwanted waste and impurities. Only one molecule of water is produced as a by-product, making for a genuinely green synthesis.

Chemical synthesis of ibuprofen.webp

 Chemical Synthesis of Ibuprofen[2]

In 2009, Andrew R. Bogdan et al. from Florida State University synthesized Ibuprofen using a microreactor. Microreactors are safer, more efficient, and more selective chemical transformations in microchannels or narrow-bore tubes. Using isobutyl benzene and propionic acid as starting materials, the total reaction time was about 10 min, and the yield was 68% crude and 51% after recrystallization (purity 99% by GC and NMR analysis).

Ibuprofen continuous synthesis process.webp

 The continuous synthesis process of Ibuprofen [3]

In 2014, Dr. David R. Snead and Professor Timothy F. Jamison of Massachusetts Institute of Technology (MIT) performed a multi-step continuous reaction using isobutyl benzene and propionyl chloride as raw materials. Ibuprofen was assembled from its basic building blocks in three minutes, with an average yield of more than 90% per step from the starting material to the target compound.

Ibuprofen continuous synthesis process (2).webp

 The continuous synthesis process of Ibuprofen [4] 

 References

[1] Ashish Singh, et al. Neuroinflammatory responses in Parkinson's disease: relevance of Ibuprofen in therapeutics. Inflammopharmacology. 2021 Feb;29(1):5-14. doi: 10.1007/s10787-020-00764-w.

[2] Mark A. Murphy. Early Industrial Roots of Green Chemistry and the history of the BHC Ibuprofen process invention and its Quality connection. Foundations of Chemistry volume 20, pages121–165 (2018).

[3]Andrew R Bogdan, et al.  The continuous-flow synthesis of Ibuprofen. Angew Chem Int Ed Engl. 2009;48(45):8547-50. doi: 10.1002/anie.200903055.

[4] David R Snead , et al. A three-minute synthesis and purification of ibuprofen: pushing the limits of continuous-flow processing. Angew Chem Int Ed Engl. 2015 Jan 12;54(3):983-7. doi:

评论

此博客中的热门博文

The Launch Meeting was Held by Medicilon and DAC Biotech of the Contract Research on ADC Preclinical Study

  Chuansha, Shanghai, Nov. 8th, 2019 — Medicilon held the launch meeting with Hangzhou DAC Biotech Co., Ltd to initiate the   preclinical study   of the antibody-drug-conjugate (ADC)  DXC005, including the   pharmacology study ,   DMPK study   and the   safety evaluation . Medicilon has previously completed integrated  preclinical research  on ADC drugs cooperating with DAC Biotech and other companies. Two of them has been approved by NMPA and entered Phase I clinical trials. About Hangzhou DAC Biotech Co., Ltd Hangzhou DAC Biotech, Co., Ltd was officially registered in HEDA Area, Hangzhou City, Zhejiang Province, China around the end of Year 2012, and is located nearby the bank of beautiful Qiantang River. The company focuses on developing conjugate of monoclonal antibody and small molecular cytotoxic drug, both of which are banded together with smart linkers. About Antibody-Drug-Conjugate (ADC) ADCs ...

Medicilon assisted Hangzhou DAC Biotech in approval of clinical study of ADC drug DAC-002

  On July 20, 2020, DAC Biotech’s new   ADC drug development , TROP2-ADC—DAC-002 was approved of clinical study by NMPA. for the indication of solid malignant tumor. Medicilon completed   preclinical pharmacokinetic  and toxicological studies in this project, accelerating the development process. DAC-002 is an ADC anti-Trop2 monoclonal antibody conjugated by an intelligent ligand against Tubulysin B analogue. It is used to treat Trop2 triple negative breast cancer, small cell lung cancer, non-small cell lung cancer and pancreatic cancer.Trop2 can promote the proliferation, invasion, metastasis and diffusion of tumor cells, and its high expression is closely related to the shortening of survival time and poor prognosis of tumor patients. Therefore, it is of great significance to study anti-tumor drugs targeted by Trop2. Reference: Medicilon Assists - The first China-made targeting folic acid receptor FRα ADC injection BAT8006 was approved for clinical use Medicilon As...

Medicilon and Binhui Biopharmaceutical Have Reached a Strategic Collaboration to Jointly Draw a New Blueprint for the Development of New Biological Drugs

  On March 18, Medicilon and Binhui Biopharmaceutical (Binui Bio) announced a strategic collaboration.  The two parties will work together to jointly explore the possibilities in cutting-edge fields such as oncolytic viruses, nucleic acid drugs and protein drugs. Gather and Work Together to Create Advantages      Facilitate the Research and Development of Oncolytic Viruses, Nucleic Acids, Proteins and Other Drugs As a one-stop biopharmaceutical comprehensive preclinical R&D service CRO, Medicilon has been developing and accumulating for 20 years, always adhering to the spirit of innovation, and has successfully constructed bi/multi-specific antibodies,  ADCs ,  mRNA vaccines ,  small nucleic acid drugs ,  PROTAC , and  CGT technical service platform  that have helped 421 INDs obtain clinical approval.  It is this outstanding achievement that has earned Medicilon wide recognition in the industry and laid a solid foundation f...